{"id":"W4413605538","doi":"10.1016/j.bneo.2025.100165","title":"Final safety and efficacy results from a phase 1/2 study of tagraxofusp, a CD123-targeted therapy, for myelofibrosis","year":2025,"lang":"en","type":"article","venue":"Blood Neoplasia","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta Hospital; Princess Margaret Cancer Centre","funders":"Menarini Group","keywords":"Myelofibrosis; Medicine; Phase (matter); Targeted therapy; Oncology; Internal medicine; Chemistry; Bone marrow; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001949541,0.0003346338,0.0008243273,0.0001899682,0.0001702046,0.00002942128,0.00009711242,0.0001240325,0.00005005411],"category_scores_gemma":[0.0003078156,0.0002588426,0.0001520012,0.0003386285,0.00006803891,0.00005119499,0.00005436289,0.0001352325,0.000003078393],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003085214,"about_ca_system_score_gemma":0.0001805621,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003377863,"about_ca_topic_score_gemma":0.0001542173,"domain_scores_codex":[0.9979857,0.00009569864,0.0007070666,0.000661359,0.0002564554,0.0002937348],"domain_scores_gemma":[0.9979119,0.001086249,0.0002023734,0.0004775318,0.0001756842,0.0001462269],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1790357,0.1287212,0.3700206,0.0004040286,0.01354569,0.0003074262,0.01703064,0.0000308897,0.03697411,0.001080431,0.008329569,0.2445197],"study_design_scores_gemma":[0.2824469,0.02125198,0.5943384,0.0004974927,0.002339317,0.00001885986,0.001115947,0.0002353842,0.0875288,0.0001317975,0.009721906,0.0003732092],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.992493,0.001297192,0.00007070301,0.001035894,0.0001124818,0.003451562,0.0009102393,0.00006143608,0.0005674824],"genre_scores_gemma":[0.9963924,0.000461453,0.001689889,0.0002396086,0.00008309472,0.0003169929,0.0003460585,0.00002659138,0.0004439177],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2441465,"threshold_uncertainty_score":0.9999864,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02681857350839703,"score_gpt":0.3159203222997793,"score_spread":0.2891017487913823,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}